Document
PGR2021-00047, No. 1023 Exhibit - Exhibit 1023 (P.T.A.B. Feb. 3, 2021)
Cite Document
PGR2021-00047, No. 1023 Exhibit - Exhibit 1023 (P.T.A.B. Feb. 3, 2021)
+ More Snippets
Document
PGR2021-00047, No. 1035 Exhibit - Exhibit 1035 (P.T.A.B. Feb. 3, 2021)
Cite Document
PGR2021-00047, No. 1035 Exhibit - Exhibit 1035 (P.T.A.B. Feb. 3, 2021)
+ More Snippets
Document
PGR2021-00047, No. 1008 Exhibit - Exhibit 1008 (P.T.A.B. Feb. 3, 2021)
Cite Document
PGR2021-00047, No. 1008 Exhibit - Exhibit 1008 (P.T.A.B. Feb. 3, 2021)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LC0V59LTXBLUEX3 (U.S. Pat. App. Dec. 27...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LC0V59LTXBLUEX3 (U.S. Pat. App. Dec. 27, 2022)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LC0V5818XBLUEX0 (U.S. Pat. App. Dec. 27...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LC0V5818XBLUEX0 (U.S. Pat. App. Dec. 27, 2022)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LBOJ0BBPXBLUEX2 (U.S. Pat. App. Dec. 1...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LBOJ0BBPXBLUEX2 (U.S. Pat. App. Dec. 14, 2022)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LBOJ0BBQXBLUEX2 (U.S. Pat. App. Dec. 1...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LBOJ0BBQXBLUEX2 (U.S. Pat. App. Dec. 14, 2022)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LBOJ0BBOXBLUEX2 (U.S. Pat. App. Dec. 1...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. LBOJ0BBOXBLUEX2 (U.S. Pat. App. Dec. 14, 2022)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KNGFE082DFLYX11 (U.S. Pat. App. Apr. 13...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KNGFE082DFLYX11 (U.S. Pat. App. Apr. 13, 2021)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KNGFE08ALDFLYX9 (U.S. Pat. App. Apr. 13...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KNGFE08ALDFLYX9 (U.S. Pat. App. Apr. 13, 2021)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KN0HYW82LDFLYX4 (U.S. Pat. App. Apr. 2,...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KN0HYW82LDFLYX4 (U.S. Pat. App. Apr. 2, 2021)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KN0HYW3NLDFLYX7 (U.S. Pat. App. Apr. 2,...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KN0HYW3NLDFLYX7 (U.S. Pat. App. Apr. 2, 2021)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KS92Y3OGLDFLYX7 (U.S. Pat. App. Aug. 5...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KS92Y3OGLDFLYX7 (U.S. Pat. App. Aug. 5, 2021)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KNKBFFY0DFLYX10 (U.S. Pat. App. Apr. 19...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KNKBFFY0DFLYX10 (U.S. Pat. App. Apr. 19, 2021)
+ More Snippets
Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KNKBFFY2LDFLYX9 (U.S. Pat. App. Apr. 19...
Cite Document
CRYSTALLINE FORM OF OREXIN RECEPTOR ANTAGONIST, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF, 16/777,121, No. KNKBFFY2LDFLYX9 (U.S. Pat. App. Apr. 19, 2021)
+ More Snippets